Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objective: We sought to evaluate accurate and reproducible detection of Myxobolus cerebralis (Mc), the causative agent of whirling disease, by using nested polymerase chain reaction (nPCR) and three previously established real-time quantitative PCR (qPCR) assays: K18S (Kelley 18S), C18S (Cavender 18S), and Hsp70 (heat shock protein 70). We used a "fit for purpose" approach combined with intra- and interlaboratory testing to identify a molecular testing method that would be equivalent to the currently accepted nPCR procedure for Mc.

Methods: Assay performance was compared using a combination of intra- and interlaboratory testing that used synthetic gBlocks along with naturally and experimentally infected fish tissue. North American isolates representing geographically distinct locations were also tested using all three assays.

Result: The K18S and C18S assays exhibited high assay sensitivity, intra- and interlaboratory repeatability of sample replicates, and reproducible identification of all test samples across multiple laboratories. In contrast, the Hsp70 assay failed to detect several positive samples at low DNA concentrations during intra- and interlaboratory testing. The K18S assay was the only procedure that demonstrated perfect detection accuracy when testing geographically distinct Mc isolates. Results demonstrated the K18S assay is robust under variable test conditions, is more accurate than the C18S and Hsp70 assays, and provides detection capabilities equivalent to those of the currently accepted nPCR confirmation assay "gold standard" that is described in the American Fisheries Society-Fish Health Section (AFS-FHS) Blue Book.

Conclusion: The "fit for purpose" approach and preliminary completion of the World Organization for Animal Health validation pathway demonstrate that the K18S assay provides an alternate method for Mc testing. This work provides the foundation for acceptance of the K18S assay into the AFS-FHS Blue Book as a standardized test procedure for Mc.

Download full-text PDF

Source
http://dx.doi.org/10.1002/aah.10220DOI Listing

Publication Analysis

Top Keywords

intra- interlaboratory
16
k18s assay
16
interlaboratory testing
12
polymerase chain
8
chain reaction
8
myxobolus cerebralis
8
"fit purpose"
8
purpose" approach
8
equivalent currently
8
currently accepted
8

Similar Publications

Objective: In the framework of the Alt-SPF consortium, a large ring study was conducted to evaluate different alternative methods for SPF determination. This paper reports and discusses the results of a new in vitro approach, the Fused Method. The study aimed to determine whether the Fused Method would provide similar SPF results to those obtained using ISO 24444 and whether UVA-PF would be comparable to ISO 24443.

View Article and Find Full Text PDF

Objective: To perform a comprehensive statistical characterization of the Double Plate method (ISO 23675) as a potential in vitro alternative to the in vivo reference method (ISO 24444:2019) for determining the sun protection factor (SPF).

Methods: Five qualified laboratories were involved in testing the Double Plate method, as part of a large-scale ring test conducted by the International Consortium 'ALT-SPF'. About 32 sunscreen products, reflecting diverse global formulations, were tested using both the in vivo reference method and the Double Plate method.

View Article and Find Full Text PDF

Reliable and comparable data from multiple laboratories are essential for networks relying on reverse transcription quantitative polymerase chain reaction (RT-qPCR)-based surveillance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genetic material in wastewater. Large-scale networks, such as those spanning Canada and the United States, depend on multiple laboratories deploying varied methods. However, the comparability of these methods and implications for data interoperability have not been rigorously examined.

View Article and Find Full Text PDF

A key parameter for the continued success of cervical cancer screening is quality-controlled use of human papillomavirus (HPV) tests that are clinically validated according to international guidelines. The clinical accuracy for cervical screening of the Allplex HPV HR Detection (Allplex), which concurrently detects and distinguishes 12 high-risk HPV types (16,18,31,33,35,39,45,51,52,56,58,59) and HPV66 and HPV68 was assessed on SurePath samples by comparing its performance to the second-generation comparator BD Onclarity HPV assay (Onclarity). The absolute clinical sensitivity, assessed on 76 samples derived from a screening population with underlying CIN2+, of Allplex and Onclarity was 98.

View Article and Find Full Text PDF